#<p>Log transformed before analysis;</p><p>*adjusted by age, gender, BMI and diabetes; NS, not significant; CCR: endogenous creatinine clearance rate; IVSTd, left ventricular end-systolic dimension; LVDd: left ventricular diastolic dimension; LVMI: left ventricular mass index; LVH: left ventricular hypertrophy.</p
Background: Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial e...
<p>Correlation coefficients and P values are from Spearman’s correlation test.</p
<p>Simple linear correlations between both FGF23 molecules and other demographic, clinical and CKD-M...
<p>*Log transformed before analysis.</p><p># adjusted by BMI, diabetes and hypertension.</p><p>NS: n...
<p>Correlations coefficients of circulating FGF21 levels for associated clinical factors.</p
<p>The analysis also included gender, BMI, diabetes, systolic pressure, CCR, eGFR, creatinine, BUN, ...
<p>Abbreviation: FGF19, fibroblast growth factor 19; BMI, body mass index; W, waist circumference; S...
<p>Regression analysis of serum levels of FGF-21 (log transformed) with HDL-cholesterol (A), Fasting...
<p>A, circulating levels of FGF21 in CKD patients with LVH were significantly higher than that of CK...
OBJECTIVE—Fibroblast growth factor 21 (FGF21) is a meta-bolic regulator with multiple beneficial eff...
Aims/hypothesis: Circulating fibroblast growth factor 21 (FGF21) levels are often elevated in obesit...
Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial effects on gl...
<p>A. Correlation between log(FGF23) and LVMI. B. Correlation between log(α-Klotho) and LVMI. Pearso...
<p>Data are expressed as mean±SD or as median (interquartil range). FGF21 was log-transformed before...
<p>The analyses also included BMI, Total Cholesterol, HDL-cholesterol, LDL-cholesterol, ApoB100, ins...
Background: Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial e...
<p>Correlation coefficients and P values are from Spearman’s correlation test.</p
<p>Simple linear correlations between both FGF23 molecules and other demographic, clinical and CKD-M...
<p>*Log transformed before analysis.</p><p># adjusted by BMI, diabetes and hypertension.</p><p>NS: n...
<p>Correlations coefficients of circulating FGF21 levels for associated clinical factors.</p
<p>The analysis also included gender, BMI, diabetes, systolic pressure, CCR, eGFR, creatinine, BUN, ...
<p>Abbreviation: FGF19, fibroblast growth factor 19; BMI, body mass index; W, waist circumference; S...
<p>Regression analysis of serum levels of FGF-21 (log transformed) with HDL-cholesterol (A), Fasting...
<p>A, circulating levels of FGF21 in CKD patients with LVH were significantly higher than that of CK...
OBJECTIVE—Fibroblast growth factor 21 (FGF21) is a meta-bolic regulator with multiple beneficial eff...
Aims/hypothesis: Circulating fibroblast growth factor 21 (FGF21) levels are often elevated in obesit...
Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial effects on gl...
<p>A. Correlation between log(FGF23) and LVMI. B. Correlation between log(α-Klotho) and LVMI. Pearso...
<p>Data are expressed as mean±SD or as median (interquartil range). FGF21 was log-transformed before...
<p>The analyses also included BMI, Total Cholesterol, HDL-cholesterol, LDL-cholesterol, ApoB100, ins...
Background: Fibroblast growth factor 21 (FGF-21) is a metabolic regulator with multiple beneficial e...
<p>Correlation coefficients and P values are from Spearman’s correlation test.</p
<p>Simple linear correlations between both FGF23 molecules and other demographic, clinical and CKD-M...